This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,078,650
Pathways to Cardiovascular Disease after Preterm Birth: Cellular and Sex-Specific Mechanisms of Cardiac Dysfunction Using a Neonatal Hyperoxia Model
CIHR · 2025 · Co-investigator
- $100,000
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
CIHR · 2023 · Co-investigator
- $450,000
The interplay between Inborn Error of Immunity and blood disorders: unravelling immune defects behind common haematological diseases
CIHR · 2023 · Principal investigator
Pathways to Cardiovascular Disease after Preterm Birth: Cellular and Sex-Specific Mechanisms of Cardiac Dysfunction Using a Neonatal Hyperoxia Model
Principal investigators: Nuyt, Anne Monique
Keywords: Cardiology; Cell Physiology; Development Origins Of Health And Disease; Prematurity
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
Principal investigators: Duval, Michel
Keywords: Adoptive Immunotherapy; Cell Therapy Manufacturing; Childhood Cancer; First-In-Human Clinical Trial; Hematopoietic Stem Cell Transplantation; Nk Cell-Based Immunotherapy
The interplay between Inborn Error of Immunity and blood disorders: unravelling immune defects behind common haematological diseases
Principal investigators: Haddad, Elie; Lavallée, Vincent-Philippe
Keywords: Autoimmunity; Blood Disorders; Genetics; Immune Dysregulation; Immunological Biomarkers; Inborn Error Of Immunity; Paediatric Immunology/Haematology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.